DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Schneeweiss A, Lux MP, Hartkopf AD. et al.
Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T‑DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167).
San Antonio Breast Cancer Symposium 2018 Abstr. P6-17-22
Access:
We do not assume any responsibility for the contents of the web pages of other providers.